keyboard_arrow_up

Spine Biologics Market Forecast to 2020: By Product Type, Surgery Type and Regional Analysis

Spinal biologics encompass materials that can be utilized in case of bone fusion surgery, spinal cord injury, and degenerative disk disease. Ten years ago, the spine treatment market constituted 75% traditional rods and plates made of metals and 25% biologics. On the other hand, biological materials are proteins that can attract and stimulate cells, promote fusion, and help in the bone healing process. The global spine biologics market is expected to reach $2.4 Billion by 2020, at a CAGR of 4.4% during the forecast period from 2015 to 2020.

Complete report on Spine Biologics Market spread across 101 Pages, Profiling 13 Companies and Supported with 55 Tables and 54 Figures is now available at http://www.reportsnreports.com/reports/443550-spine-biologics-market-by-product-type-bone-graft-bine-graft-substitute-platelet-rich-plasma-bmac-surgery-type-anterior-cervical-discectomy-and-fusion-posterior-lumbar-interbody-fusion-end-user-and-geography-global-forecast-to-2020.html

The global spine biologics market has been categorized by regions into North America, Europe, Asia-Pacific, and the Rest of the World. North America is the most dominant region in the global market, followed by Europe. Bone graft substitute segment dominated the North American spine biologics market.


“The global spine biologics market report studies the major regions, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW).”


Spine biologics find application in spine surgery as lieu allografts as well as a support for bones in and around the spinal region. They can also be used cure the spinal injuries or trauma or degenerated discs. Currently, bone morphogenetic proteins (BMP’s) are biologic materials that are predominantly used in spinal surgery. Bone graft substitutes claim for around 85% share of the total spine biologics market.


Spine Biologics Market, By Surgery Type

·         Anterior Cervical Discectomy and Fusion (ACDF)

·         Posterior Lumbar Interbody Fusion (PLIF)

·         Transforaminal Lumbar Interbody Fusion (TLIF)

·         Anterior Lumbar Interbody Fusion (ALIF)

·         Lateral Lumbar Interbody Fusion (LLIF)


By product type, the spine biologics market is categorized into four types, namely, bone graft substitutes, bone grafts, platelet-rich plasma (PRP), and bone marrow aspirate concentrate therapy. In 2014, the bone graft substitutes segment contributed the largest share of 84.1% to the global market.


Get the Sample Copy of this Research Now

http://www.reportsnreports.com/contacts/requestsample.aspx?name=443550


By surgery type, the market is segmented into: anterior cervical discectomy and fusion (ACDF), transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF), and other surgeries. The ACDF segment contributed the largest share to the global spine biologics market in 2014, followed by the transforaminal lumbar interbody fusion (TLIF) segment.


Some of the major players in the spine biologics market are Medtronic Inc. (U.S.), DePuy Synthes Companies (U.S.), Zimmer Holding Inc. (U.S.), Nuvasive Inc. (U.S.), Stryker Corporation (U.S.), Orthofix international N.V. (U.S.), K2M Inc. (U.S.), Exactech Inc. (U.S.), Wright Medical Technology Inc. (U.S.), and others.


Click now for more Details, Queries and Discount on this study “Spine Biologics Market by Product Type (Bone Graft, Bine Graft Substitute, Platelet Rich Plasma, BMAC), Surgery Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography - Global Forecast to 2020” report @ http://www.reportsnreports.com/contacts/discount.aspx?name=443550


Key stakeholders of this market include spine biologics manufacturing companies, medical device distributors, healthcare institutions (hospitals, medical schools and governing bodies), health insurance players, research and consulting firms, and regulatory authorities (FDA).


In 2015, North America estimated accounted for the largest share of the global spine biologics market. As growth of healthcare industry is affected by the healthcare expenditure, increased investments in life sciences are expected to fuel the growth of the global spine biologics market in this region. The European spine biologics market is the second-largest. APAC is estimated to be the fastest growing market for spine biologics during the forecast period.


Explore more reports on Medical Devices at www.reportsnreports.com/market-research/medical-devices/


About Us:

ReportsandReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@reportsandreports.com